Cell-free DNA analysis in current cancer clinical trials: a review
2022 · British Journal of Cancer · 192 citations
https://doi.org/10.1038/s41416-021-01696-0
A
Alberto Cedro‐Tanda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
784
Citations
15
h-index
22
i10-index
Alberto Cedro‐Tanda is an academic researcher from National Institute of Genomic Medicine. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 15, co-authored 51 publications.
ORCID: 0000-0001-8708-462XPapers by this author
worksA lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype
2020 · Scientific Reports · 33 citations
https://doi.org/10.1038/s41598-020-69905-z
Prevalence of HMTV in breast carcinomas and unaffected tissue from Mexican women
2014 · BMC Cancer · 23 citations
https://doi.org/10.1186/1471-2407-14-942
LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer
2024 · Scientific Reports · 13 citations
https://doi.org/10.1038/s41598-024-51947-2
End-point RT-PCR based on a conservation landscape for SARS-COV-2 detection
2022 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-022-07756-6
End-point RT-PCR based on a conservation landscape for SARS-COV-2 detection
2022 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-022-07756-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat